The round, which kicked off on April 8, is capped at $15 million, with $2.5 million remaining to be sold. Funds raised will be used fo “payments of salary in the ordinary course of business,” the filing indicated.
Read More
Precision Biosciences’ two-year collaboration with Gilead Sciences to develop new therapies to cure hepatitis B will end in September. Here’s what’s going on.
Read More
Precision BioSciences, a Durham-based genome editing company, has reached two regulatory milestones for its potential therapy against multiple myeloma, a chronic cancer of white blood cells.
Read More
Scientists have developed a new gene-editing technology that could potentially correct up to 89% of genetic defects, including those that cause diseases like sickle cell anemia.
Read More
The potential for gene therapy to actually cure debilitating and deadly genetic disorders got another window opened today with a collaboration between two cutting-edge companies from North Carolina and the Boston area.
Read More
RESEARCH TRIANGLE PARK – From “find it and fix it” to “anticipate and mitigate.” That’s how Ralph Snyderman, M.D. — chancellor emeritus at Duke University — explains the journey from traditional medicine to personalized healthcare, which is playing an increasingly important role at clinics and hospitals across the country....
Read More
Pairwise, a gene editing and plant technology start-up, is moving its initial San Diego footprint to newly established headquarters in leased space on the Golden Belt Campus in the heart of downtown Durham. Here’s the backstory.
Read MoreMichael Stocum has resigned as chief executive officer at Inviata, a clinical cancer genomics company with operations in the Triangle and U.K.
Read More
Metabolon, a global leader in the study of biological data based on metabolomics, is partnering with a genomics services company to provide analysis of biological samples from US veterans that are part of a US Department of Veterans Affairs project, the results of which could lead to advances in personalized medicine
Read More
